176 related articles for article (PubMed ID: 30487198)
1. Soluble PD-L1 is a potential biomarker of cutaneous melanoma aggressiveness and metastasis in obstructive sleep apnoea patients.
Cubillos-Zapata C; Martínez-García MÁ; Campos-Rodríguez F; Sánchez de la Torre M; Nagore E; Martorell-Calatayud A; Hernández Blasco L; Chiner Vives E; Abad-Capa J; Montserrat JM; Cabriada-Nuño V; Cano-Pumarega I; Corral-Peñafiel J; Diaz-Cambriles T; Mediano O; Somoza-González M; Dalmau-Arias J; Almendros I; Farré R; López-Collazo E; Gozal D; García-Río F;
Eur Respir J; 2019 Feb; 53(2):. PubMed ID: 30487198
[TBL] [Abstract][Full Text] [Related]
2. Obesity attenuates the effect of sleep apnea on active TGF-ß1 levels and tumor aggressiveness in patients with melanoma.
Cubillos-Zapata C; Martínez-García MÁ; Díaz-García E; Jaureguizar A; Campos-Rodríguez F; Sánchez-de-la-Torre M; Nagore E; Martorell-Calatayud A; Blasco LH; Pastor E; Abad-Capa J; Montserrat JM; Cabriada-Nuño V; Cano-Pumarega I; Corral-Peñafiel J; Arias E; Mediano O; Somoza-González M; Dalmau-Arias J; Almendros I; Farré R; López-Collazo E; Gozal D; García-Río F
Sci Rep; 2020 Sep; 10(1):15528. PubMed ID: 32968152
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers of carcinogenesis and tumour growth in patients with cutaneous melanoma and obstructive sleep apnoea.
Santamaria-Martos F; Benítez I; Girón C; Barbé F; Martínez-García MA; Hernández L; Montserrat JM; Nagore E; Martorell A; Campos-Rodriguez F; Corral J; Cabriada V; Abad J; Mediano O; Troncoso MF; Cano-Pumarega I; Fortuna Gutierrez AM; Diaz-Cambriles T; Somoza-Gonzalez M; Almendros I; Farre R; Gozal D; Sánchez-de-la-Torre M;
Eur Respir J; 2018 Mar; 51(3):. PubMed ID: 29519923
[TBL] [Abstract][Full Text] [Related]
4. Age-dependent hypoxia-induced PD-L1 upregulation in patients with obstructive sleep apnoea.
Cubillos-Zapata C; Balbás-García C; Avendaño-Ortiz J; Toledano V; Torres M; Almendros I; Casitas R; Zamarrón E; García-Sánchez A; Feliu J; Aguirre LA; Farre R; López-Collazo E; García-Rio F
Respirology; 2019 Jul; 24(7):684-692. PubMed ID: 30656807
[TBL] [Abstract][Full Text] [Related]
5. Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint Blockade.
Zhou J; Mahoney KM; Giobbie-Hurder A; Zhao F; Lee S; Liao X; Rodig S; Li J; Wu X; Butterfield LH; Piesche M; Manos MP; Eastman LM; Dranoff G; Freeman GJ; Hodi FS
Cancer Immunol Res; 2017 Jun; 5(6):480-492. PubMed ID: 28522460
[TBL] [Abstract][Full Text] [Related]
6. Soluble PD-L1 Expression in Circulation as a Predictive Marker for Recurrence and Prognosis in Gastric Cancer: Direct Comparison of the Clinical Burden Between Tissue and Serum PD-L1 Expression.
Shigemori T; Toiyama Y; Okugawa Y; Yamamoto A; Yin C; Narumi A; Ichikawa T; Ide S; Shimura T; Fujikawa H; Yasuda H; Hiro J; Yoshiyama S; Ohi M; Araki T; Kusunoki M
Ann Surg Oncol; 2019 Mar; 26(3):876-883. PubMed ID: 30565045
[TBL] [Abstract][Full Text] [Related]
7. Pre-treatment serum levels of soluble programmed cell death-ligand 1 predict prognosis in patients with hepatitis B-related hepatocellular carcinoma.
Han X; Gu YK; Li SL; Chen H; Chen MS; Cai QQ; Deng HX; Zuo MX; Huang JH
J Cancer Res Clin Oncol; 2019 Feb; 145(2):303-312. PubMed ID: 30267213
[TBL] [Abstract][Full Text] [Related]
8. [The content of the soluble forms PD-1 and PD-L1 in blood serum of patients with gastric cancer and their relationship with clinical and morphological characteristics of the disease.].
Gershtein ES; Ognerubov NA; Chang VL; Delektorskaya VV; Korotkova EA; Sokolov NY; Polikarpova SB; Stilidi IS; Kushlinskii NE
Klin Lab Diagn; 2020; 65(6):347-352. PubMed ID: 32459892
[TBL] [Abstract][Full Text] [Related]
9. Soluble Programmed Cell Death Ligand 1 as a Novel Biomarker for Nivolumab Therapy for Non-Small-cell Lung Cancer.
Okuma Y; Wakui H; Utsumi H; Sagawa Y; Hosomi Y; Kuwano K; Homma S
Clin Lung Cancer; 2018 Sep; 19(5):410-417.e1. PubMed ID: 29859759
[TBL] [Abstract][Full Text] [Related]
10. Serum sPD-1 and sPD-L1 as Biomarkers for Evaluating the Efficacy of Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients.
Li Y; Cui X; Yang YJ; Chen QQ; Zhong L; Zhang T; Cai RL; Miao JY; Yu SC; Zhang F
Clin Breast Cancer; 2019 Oct; 19(5):326-332.e1. PubMed ID: 31176611
[TBL] [Abstract][Full Text] [Related]
11. Sleep-Disordered Breathing Is Independently Associated With Increased Aggressiveness of Cutaneous Melanoma: A Multicenter Observational Study in 443 Patients.
Martinez-Garcia MA; Campos-Rodriguez F; Nagore E; Martorell A; Rodriguez-Peralto JL; Riveiro-Falkenbach E; Hernandez L; Bañuls J; Arias E; Ortiz P; Cabriada V; Gardeazabal J; Montserrat JM; Carrera C; Corral J; Masa JF; de Terreros JG; Abad J; Boada A; Mediano O; de Eusebio E; Chiner E; Landete P; Mayos M; Fortuño A; Barbé F; Sánchez de la Torre M; Sanchez de la Torre A; Cano I; Gonzalez C; Pérez-Gil A; Gómez-García T; Cullen D; Somoza M; Formigón M; Aizpuru F; Navarro C; Selma-Ferrer MJ; Garcia-Ortega A; de Unamuno B; Almendros I; Farré R; Gozal D;
Chest; 2018 Dec; 154(6):1348-1358. PubMed ID: 30059679
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of soluble programmed death-ligand 1 (sPD-L1) in patients with primary central nervous system diffuse large B-cell lymphoma.
Cho I; Lee H; Yoon SE; Ryu KJ; Ko YH; Kim WS; Kim SJ
BMC Cancer; 2020 Feb; 20(1):120. PubMed ID: 32054467
[TBL] [Abstract][Full Text] [Related]
13. Tumor associated PD-L1 expression pattern in microscopically tumor positive sentinel lymph nodes in patients with melanoma.
Tarhini AA; Zahoor H; Yearley JH; Gibson C; Rahman Z; Dubner R; Rao UN; Sander C; Kirkwood JM
J Transl Med; 2015 Sep; 13():319. PubMed ID: 26419843
[TBL] [Abstract][Full Text] [Related]
14. Association between sleep disordered breathing and aggressiveness markers of malignant cutaneous melanoma.
Martínez-García MÁ; Martorell-Calatayud A; Nagore E; Valero I; Selma MJ; Chiner E; Landete P; Montserrat JM; Carrera C; Pérez-Gil A; Campos-Rodríguez F; Farré R
Eur Respir J; 2014 Jun; 43(6):1661-8. PubMed ID: 24659545
[TBL] [Abstract][Full Text] [Related]
15. Soluble Ligand of the Immune Checkpoint Receptor (sPD-L1) in Blood Serum of Patients with Renal Cell Carcinoma.
Kushlinskii NE; Gershtein ES; Morozov AA; Goryacheva IO; Filipenko ML; Alferov AA; Bezhanova SD; Bazaev VV; Kazantseva IA
Bull Exp Biol Med; 2019 Jan; 166(3):353-357. PubMed ID: 30627905
[TBL] [Abstract][Full Text] [Related]
16. [Level of soluble programmed death-1 ligand 1 in peripheral blood of patients with advanced epidermal growth factor receptor mutated lung adenocarcinoma and its clinical implications].
Zhang LQ; Chen Y; Pan X; Xing YF; Shi MH; Chen YJ
Zhonghua Yi Xue Za Zhi; 2016 Dec; 96(48):3870-3874. PubMed ID: 28057155
[No Abstract] [Full Text] [Related]
17. Obstructive sleep apnoea is related to melanoma aggressiveness through paraspeckle protein-1 upregulation.
Cubillos-Zapata C; Martínez-García MÁ; Díaz-García E; García-Tovar S; Campos-Rodríguez F; Sánchez-de-la-Torre M; Nagore E; Martorell-Calatayud A; Blasco LH; Pastor E; Abad-Capa J; Montserrat JM; Cabriada-Nuño V; Cano-Pumarega I; Corral-Peñafiel J; Arias E; Mediano O; Somoza-González M; Dalmau-Arias J; Almendros I; Farré R; Gozal D; García-Río F;
Eur Respir J; 2023 Feb; 61(2):. PubMed ID: 36265878
[TBL] [Abstract][Full Text] [Related]
18. Soluble programmed death-ligand 1 are highly expressed in peripheral T-cell lymphoma: a biomarker for prognosis.
Shen H; Ji Y; Zhou D; Zhang Y; Wang W; Sun J; Zhang W
Hematology; 2019 Dec; 24(1):392-398. PubMed ID: 30890046
[TBL] [Abstract][Full Text] [Related]
19. Study of Serum Soluble Programmed Death Ligand 1 as a Prognostic Factor in Hepatocellular Carcinoma in Egyptian Patients.
El-Gebaly F; Abou-Saif S; Elkadeem M; Helmy A; Abd-Elsalam S; Yousef M; Elkhouly RA; Amer IF; El-Demerdash T
Curr Cancer Drug Targets; 2019; 19(11):896-905. PubMed ID: 31538897
[TBL] [Abstract][Full Text] [Related]
20. The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma.
Paek SC; Griffith KA; Johnson TM; Sondak VK; Wong SL; Chang AE; Cimmino VM; Lowe L; Bradford CR; Rees RS; Sabel MS
Cancer; 2007 Jan; 109(1):100-8. PubMed ID: 17146784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
